Search results
Results from the WOW.Com Content Network
The Southern Hound was a tall, heavy dog with a square head, and long ears. It had a deep chest, a long bony body and a deep melodious voice. It was a slow dog, but with excellent scenting abilities and was employed to follow the trail of the quarry during a hunt.
The COVID-19 pandemic in Southeast Asia is part of the ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was confirmed to have spread to Southeast Asia on 13 January 2020, when a 61-year-old woman from Wuhan tested positive in Thailand , making it the ...
Infection rates dropped and stabilised throughout 2022 and 2023, leading to the end of COVID-19's classification as a severe transmissible disease in June 2023. [22] Although the pandemic has heavily disrupted the country's economy, [23] Vietnam's GDP growth rate has remained one of the highest in Asia-Pacific, at 2.91% in 2020. Due to the more ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
A police car in Hanoi with COVID-19 public health messaging. The Vietnamese government using social media platforms to keep the public informed of COVID-19 news and instructions. Thong Tin Chinh Phu (Governmental Information), the government's official Facebook page, provides nearly hourly updates on the country's pandemic situation. Zalo, a ...
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
The Maldives declared a public health emergency over COVID-19 on 12 March. [69] On 27 March, the government announced the first confirmed case of a Maldivian citizen with COVID-19, a passenger who had returned from the United Kingdom. This brought the total number of confirmed cases in the country to 16; the other 15 were foreign citizens. [70]
The phase III study is the adaptive, multicenter, randomized, double-blind, placebo control study to evaluate the safety, immunogenicity, and efficacy of the Nanocovax vaccine against COVID-19 in volunteer subjects 18 years of age and older. [17]